BTG Overview

  • Year Founded
  • 1948

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 1,600

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 6

  • Investments
  • 20

BTG General Information

Description

BTG PLC is a biotechnology company that develops products in specialty areas of medicine. The company's three operating segments are interventional medicine, pharmaceuticals, and licensing. Its interventional medicine focuses on oncology, vascular treatments, and pulmonology. The revenue is roughly split between these three segments, while its oncology operations lead the interventional segment. The company has been known to utilize acquisitions for investing in leading therapies and capabilities.

Contact Information

Website
btgplc.com
Formerly Known As
British Technology Group
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Acquirer
Boston Scientific
Corporate Office
  • 300 Boston Scientific Way
  • Marlborough, MA 01752
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BTG Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BTG‘s full profile, request access.

Request a free trial

BTG Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
BTG PLC is a biotechnology company that develops products in specialty areas of medicine. The company's three operating
Discovery Tools (Healthcare)
Marlborough, MA
1,600 As of 2019
00000
0.000 0000-00-00
000000&0 00000

000000

m dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt
000000000000000
Basel, Switzerland
00000 As of 0000
0000
000000000 0000

00000

ed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad min
000000000000000
Mumbai, India
00000 As of 0000
0000 0000-00-00
0&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BTG Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Novartis Corporation Basel, Switzerland 00000 0000 000000000 0000
Cipla Corporation Mumbai, India 00000 0&0
Biocon Formerly PE-Backed Bengaluru, India 00000 000.00 00000000 000.00
Glenmark Corporation Mumbai, India 00000 00000 000000000 00000
Pfizer (Pharmaceuticals) Corporation New York, NY 00000 000.00 0000 000.00
You’re viewing 5 of 11 competitors. Get the full list »

BTG Patents

BTG Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230190356-A1 High pressure, low temperature coupling Pending 17-Dec-2021 000000000
US-20200352945-A1 Platinum-resistant cancer treatment Inactive 01-Jun-2017 0000000000
US-11026948-B2 Platinum-resistant cancer treatment Active 01-Jun-2017 0000000000 00
US-20210252001-A1 Platinum-resistant cancer treatment Pending 01-Jun-2017 0000000000
CA-3062552-A1 Platinum-resistant cancer treatment Pending 16-May-2017 A61K31/517
To view BTG’s complete patent history, request access »

BTG Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BTG Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BTG‘s full profile, request access.

Request a free trial

BTG Investments & Acquisitions (20)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Opy Health 15-Aug-2023 0000000000 Other Healthcare Services
Chengdu New Radiomedicine Technology 18-Jul-2019 00000 0000 000.00 Pharmaceuticals
Veran Medical Technologies 13-Nov-2018 00000 0000 0000 Diagnostic Equipment 000000 00
NOvate Medical Technologies 07-Sep-2018 0000000000 00000 Other Devices and Supplies 000000 00
Roxwood Medical 05-Oct-2017 Merger/Acquisition 0000 Surgical Devices 0000 0000
You’re viewing 5 of 20 investments and acquisitions. Get the full list »

BTG Subsidiaries (6)

Company Name Industry Location Founded
Opy Health Other Healthcare Services Sao Paulo, Brazil 2020
BTG Ventures Corporate Venture Capital London, United Kingdom 0000
Galil Medical Therapeutic Devices Saint Paul, MN 0000
Protherics Drug Discovery Runcorn, United Kingdom 0000
Biocompatibles International Pharmaceuticals Farnham, United Kingdom 0000
You’re viewing 5 of 6 subsidiaries. Get the full list »

BTG Exits (8)

Company Name Exit Date Exit Type Exit Size Status Buyers
Veran Medical Technologies 13-Nov-2018 00000 00000 00 0000 Completed
  • 000
Xention 23-Nov-2010 00000 00000 00 000.00 Completed
  • 5 buyers
Avera Pharmaceuticals 16-Jan-2008 00000 00000 00 00.00 Completed
  • 14 buyers
Xention 18-Jul-2005 00000 00000 00 000.00 Completed
  • 6 buyers
Mesophotonics 29-Jan-2004 Early Stage VC 0000 Completed
  • 4 buyers
You’re viewing 5 of 8 exits. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »